Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Contralateral suppression of transient otoacoustic emissions in 42 premature babies (84 ears; post-conceptional age [
PCA
] 30-36 weeks) was compared to that of 39 full-term babies (78 ears;
PCA
: 37-45 weeks). Eighteen healthy adults and ten young children (5-14 years old) were studied as controls. Risk factors for hearing loss were registered in both preterm and full-term groups. An ILO-92 otoacoustic emission recording system was used to deliver linear clicks to the ear examined and broadband noise to the contralateral ear in an alternating on and off mode. Suppression in full-term babies was statistically higher than in preterms, whereas no differences existed between children and adults and children and full-terms. Peripheral auditory lateralization was evident in adults but was observed only as a trend in newborns. Only
prematurity
at the time of examination and aminoglycoside treatment for more than seven days had a negative impact on suppression. The results support the conclusion that maturation of the efferent system takes place from 30 to 45 weeks
PCA
. The exact age at which this maturation is accomplished has not yet been clearly determined.
...
PMID:Maturation of the auditory system: 2. Transient otoacoustic emission suppression as an index of the medial olivocochlear bundle maturation. 1753 May 12